Talar Derashodian

Radiation Oncologist, Brachytherapist, teacher, part of Curitherapies’ team

[Advanced Prostate Cancer Consensus Conference @APCCC_Lugano]

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial out in @EUplatinum

https://t.co/ln9jMk6uBr

The PACE-A trial is a phase 3⃣ randomized study comparing patient-reported outcomes between stereotactic body radiotherapy☢️ (SBRT) and prostatectomy in men with low- to intermediate-risk localized #ProstateCancer

It assessed health-related quality of life, focusing on urinary incontinence, bowel function, and sexual health two years after treatment.

Results showed that SBRT led to significantly less urinary incontinence and better sexual function, while prostatectomy resulted in better bowel scores.

However, SBRT was associated with slightly more bowel issues. These findings provide important insights for treatment decisions in localized prostate cancer.

@nickva1
@royalmarsdenNHS
@alison_tree
@DrTolan
@EmmaHall71

[Jonathan Khalifa 🎗️ @jnt_khalifa]

@GertMeerleer reminds us that Moses was given a 11th commandment in Mount Sinaï.. Luckily, 3500 years later, @_ShankarSiva and other #rccsbrt prophets disobeyed and proved that radiotherapy could cure localized RCC patients. @GFRU_RO #GFRU24 #renalcancer #FastrackII

[Curietherapi.es @curietherapies]

#Curietherapies2023 in underway with a great talk on guiding principles for a new program implantation

[Curietherapi.es @curietherapies]

Registration is now open!

[Dr. Andrew Loblaw @DrAndrewLoblaw]

Thank you for 20 years of Leadership and Support #HimuLukka #GUROC22

And welcome to the new co-chairs Scott Morgan ⁦@niazi_Dr7⁩

[Tarik Benidir @TarikBenidir]

Happy to share our @CleClinicUro findings: high risk Decipher scores are associated with the presence of Cribriform either alone or in combination with Intraductal Carcinoma features at RP. https://t.co/0ft6sROzEE

[Talar Derashodian @TalarD]

@DrAndrewLoblaw Agreed

[Talar Derashodian @TalarD]

@DrAndrewLoblaw No! Not enough data for SOC. The recurrence rate is too high also. She discussed it more in the post-BT salvage setting or as a boost to EBRT.

[EngerLab @EngerLab]

Yujing @yujingzou and Fabian @Naib4f enjoying themselves at the @curietherapies! Future of #brachytherapy is bright!
#curietherapies2022 @McGillMedPhys
#Thisisbrachytherapy

[Talar Derashodian @TalarD]

A great conclusin to a great meeting with Dr Cynthia Menard discussing focal prostate brachytherapy @curietherapies #Curietherapies2022

[Curietherapi.es @curietherapies]

Dr Marjory Jolicoeur @jolicom shared her experience of 2-fractions in one day HDR monotherapy for prostate cancer. #curietherapies2022 #brachytherapy

[Curietherapi.es @curietherapies]

Will Dr Morton give the answer to this eternal debate? Is biochemical failure in prostate cancer a surrogate endpoint for survival?#curietherapies2022 #brachytherapy

[Talar Derashodian @TalarD]

Josh Yamada and @stef_corradini discussing ways to move brachytherapy forward! #Curietherapies2022 #brachytherapy

[Curietherapi.es @curietherapies]

Very interesting! Brachytherapy for bone metastasis talk delivered by Dr Josh Yamaha #curietherapies2022

[Curietherapi.es @curietherapies]

Great talk ongoing by Dr Peter Hoskin on oesophageal and bronchus brachytherapy! #Curietherapies2022 #brachytherapy

[Curietherapi.es @curietherapies]

The third day started with Dr Phillip Develin talkin about skin brachytherapy. #curietherapies2022

[Curietherapi.es @curietherapies]

Dr Fleur Huang started the day early with a presentation on cervix brachytherapy and the EMBRACE studies #curietherapies2022 #brachytherapy

[Curietherapi.es @curietherapies]

First part of the hands-on breast implant workshop is a success. Second part scheduled today! #Curietherapies2022

[Abbasinejad Enger, PhD. @DrShirinAEnger]

How to attract trainees in brachytherapy? What an excellent talk by @DrMarkCorkum @curietherapies! #Thisisbrachytherapy #Curietherapies2022

[Curietherapi.es @curietherapies]

Ongoing case discussions about 2nd breast conservation therapy. #Curietherapies2002 #brachytherapy